Protecting Innovation: Exclusive Interview Expert Strategies for Trademark and Patent Management in Biotech and Beyond 18 LAWYER MONTHLY NOVEMBER 2024 In an increasingly competitive global marketplace, the management of intellectual property (IP) is paramount for businesses, particularly in the dynamic fields of biotechnology and innovation. This article features insights from Martin MacLean and Rebecca Tew, partners at Mathys & Squire, who share their expertise on navigating the challenges of trademark and patent management. From contentious and noncontentious trademark work to effective strategies for securing and enforcing patent rights, their perspectives highlight the critical considerations that businesses must address to maintain a competitive edge and protect their valuable IP assets. Martin MacLean: When managing patent portfolios in biotech fields such as protein therapeutics, antibodies, and vaccines, what are the key challenges you face, and how do you ensure your clients maintain a competitive edge globally? Managing patent portfolios in the biotech sectors, including protein therapeutics,
RkJQdWJsaXNoZXIy Mjk3Mzkz